title: Modeling the response of a biofilm to silver-based antimicrobial.
abstract: Biofilms are found within the lungs of patients with chronic pulmonary infections, in particular patients with cystic fibrosis, and are the major cause of morbidity and mortality for these patients. The work presented here is part of a large interdisciplinary effort to develop an effective drug delivery system and treatment strategy to kill biofilms growing in the lung. The treatment strategy exploits silver-based antimicrobials, in particular, silver carbene complexes (SCC). This manuscript presents a mathematical model describing the growth of a biofilm and predicts the response of a biofilm to several basic treatment strategies. The continuum model is composed of a set of reaction-diffusion equations for the transport of soluble components (nutrient and antimicrobial), coupled to a set of reaction-advection equations for the particulate components (living, inert, and persister bacteria, extracellular polymeric substance, and void). We explore the efficacy of delivering SCC both in an aqueous solution and in biodegradable polymer nanoparticles. Minimum bactericidal concentration (MBC) levels of antimicrobial in both free and nanoparticle-encapsulated forms are estimated. Antimicrobial treatment demonstrates a biphasic killing phenomenon, where the active bacterial population is killed quickly followed by a slower killing rate, which indicates the presence of a persister population. Finally, our results suggest that a biofilm with a ready supply of nutrient throughout its depth has fewer persister bacteria and hence may be easier to treat than one with less nutrient.
authors.affiliation: The University of Akron, Department of Mathematics, Akron, OH 44325-4002, USA.
authors.forename: A E
authors.initials: AE
authors.lastname: Stine
authors.forename: D
authors.initials: D
authors.lastname: Nassar
authors.forename: J K
authors.initials: JK
authors.lastname: Miller
authors.forename: C B
authors.initials: CB
authors.lastname: Clemons
authors.forename: J P
authors.initials: JP
authors.lastname: Wilber
authors.forename: G W
authors.initials: GW
authors.lastname: Young
authors.forename: Y H
authors.initials: YH
authors.lastname: Yun
authors.forename: C L
authors.initials: CL
authors.lastname: Cannon
authors.forename: J G
authors.initials: JG
authors.lastname: Leid
authors.forename: W J
authors.initials: WJ
authors.lastname: Youngs
authors.forename: A
authors.initials: A
authors.lastname: Milsted
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects* / Q000254:growth & development; D006801:Humans; D008954:Models, Biological; D053769:Nanocapsules / Q000008:administration & dosage; D011108:Polymers / Q000008:administration & dosage; D012834:Silver / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D053769:Nanocapsules; D011108:Polymers; D012834:Silver